However, a very high tumor mutational burden at baseline (18 mut/MB) was noted which would be anticipated to predict response to immune checkpoint inhibition even without PD-L1 expression via generation of higher neoantigen burden facilitating deeper and more durable responses with immune checkpoint inhibition78. Here, CD274 is linked to neoplasm.